11.04.2016
- Honeywell has signed a multi-year agreement with China’s Juhua Group for the supply of its refrigerant Solstice yf. Under the terms of the deal, Juhua will make Solstice yf in...
11.04.2016
- Eli Lilly and AstraZeneca are moving into Phase 3 of their Amaranth study of AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor that could be a potential treatment...
11.04.2016
- Two fires that broke out at the respective refineries of LyondellBasell and ExxonMobil in the Houston, Texas, area on Apr. 7 and 8 are believed to have caused extensive damage, but...
08.04.2016
- Aesica Pharmaceuticals has doubled development capacity at its site in Queenborough, Kent, UK, giving it the capability to manufacture multiple drug products up to Phase III...
08.04.2016
- A fresh dispute has sprung up at Grangemouth in Scotland, and once again Ineos, with its massive presence in the region between Glasgow and Edinburgh, is at the center. This time...
08.04.2016
- Getting back to business after the collapse of the plan to take over Swiss rival Syngenta, Monsanto’s CEO, Hugh Grant, told journalists this week the company no longer sees “large...
08.04.2016
- US manipulated seeds specialist DuPont Pioneer and China’s Origin Agritech, a biotechnology-focused crop seed provider listed on the US stock market, have signed a commercial...
08.04.2016
- Major UK energy company BP has signed an agreement with Kuwait Petroleum Corporation (KPC) to explore possible joint opportunities in oil, gas and petrochemicals. BP and KPC said...
08.04.2016
- Chlorvinyls producer Inovyn is to convert its mercury-based chlorine plant in Stenungsund, Sweden, to membrane technology as part of its commitment to phase out mercury cellroom...
07.04.2016
- US drug maker Gilead Sciences is to pay $400 million to Nimbus Therapeutics for its subsidiary Nimbus Apollo and its Acetyl-CoA Carboxylase (ACC) inhibitor program. The ACC program...
